RESUMO
To compare the efficacy of intravenous magnesium sulfate and conventional treatment with conventional treatment alone in acute severe asthma in children of age group 5 to 15 years known cases of bronchial asthma. Randomized control trial. Indoor and outdoor patients of pediatrics department of DHQ hospital, Faisalabad. Six months. In this study, 43.58%[n=17] in Exposed and 53.85% [n=21] in Un-exposed group were male and remaining 56.42%[n=22] and 46.15%[n=18] were females, mean pulse rate in both groups was recorded which shows 97.32 +/- 6.58 in Exposed Group and 103.67 +/- 8.32 in Un-exposed Group, p value was calculated as 0.02, mean FEV1 rate in both groups was recorded which shows 60.32 +/- 7.56 in Exposed Group and 54.07 +/- 6.43 in Un-exposed Group, p value was calculated as 0.03. We concluded that intravenous magnesium sulfate along with conventional treatment is significantly better than conventional treatment alone for the management of acute severe asthma attack